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CHAPTER 1 
 
  INTRODUCTION 
 
1.1 Problem Statement 
Von Willebrand Disease (VWD) is the most common hereditary coagulation 
abnormality, presenting in an estimated 1% of the population.1–4 Von Willebrand 
Disease (VWD) can also be acquired as a result of other medical conditions such as 
autoimmune disorders.4 In those with VWD, there is a deficiency or dysfunction of von 
Willebrand Factor (VWF) depending on the type of VWD.1–4 Von Willebrand Factor 
(VWF) is a plasma protein that controls platelet hemostatic function and stabilizes blood 
clotting with factor VIII. Those with VWD often experience issues with mucosal bleeding: 
frequent nosebleeds, heavy menstrual bleeding, and excessive bleeding after injury or 
surgical procedures, including dental extractions.1–4  
Gingival bleeding is not considered a true symptom, but is experienced by many 
individuals that have VWD. Based upon current evidence, a positive relationship exists 
between plaque accumulation and gingival inflammation and bleeding.5–7 Many studies 
have shown this relationship, using the experimental gingivitis model, giving evidence 
that the more supragingival plaque that exists, the more gingival bleeding and 
inflammation.5–7 
Anecdotally, many people with VWD attribute gingival bleeding to the VWD condition 
itself since symptoms include mucosal bleeding. However, no studies have shown a 
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correlation between VWD and gingival bleeding when adjusting for possible 
confounding factors such as plaque accumulation, demographics, dental care utilization, 
or oral hygiene habits. 
Those individuals with VWD are usually referred to a bleeding disorder treatment 
center to consult with a hematologist. As many VWD patients have poor oral hygiene 
from fear of causing gingival bleeding with plaque removal methods such as brushing 
the gums and flossing subgingivally,3 some bleeding disorder treatment centers have 
employed dental hygienists to provide oral hygiene education. It is also hypothesized 
that many VWD patients do not attend preventive routine dental appointments due to 
fear of excess bleeding and treatment complications.8 
1.2 Goal Statement 
This cross-sectional study will generate pilot data to examine the correlation 
between VWD severity and gingival bleeding, assess the oral hygiene habits and dental 
care utilization in women with VWD, and address the effectiveness of having a dental 
hygienist to provide valuable oral hygiene education and instruction to patients with 
VWD. Ultimately, this information will give insight to the correlation between VWD and 
gingival bleeding while controlling for plaque score and other possible confounding 
variables.  
1.3 Specific Aims 
The aims of the study are as follows… 
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Specific Aim 1: To determine the relationship between von Willebrand factor 
(VWF) levels and gingival bleeding in adult women with von Willebrand 
Disease (VWD). 
Null Hypothesis (H0): In women with VWD, the amount of gingival bleeding will be 
no different regardless of VWF levels. 
Alternative Hypothesis (H1): In women with VWD, the amount of gingival bleeding 
will be higher in those women with lower VWF levels. 
Specific Aim 2: To determine the oral hygiene habits and dental care utilization 
in those with von Willebrand Disease (VWD). 
Null Hypothesis (H0): Women with VWD who have received oral hygiene 
education from a dental hygienist at their bleeding disorder treatment center 
frequently to at every visit are as likely to have regular preventive dental 
appointments and better oral hygiene habits as women with VWD that have not had 
oral hygiene education from a dental hygienist at their bleeding disorder treatment 
center. 
Alternative Hypothesis (H1): Women with VWD who have received oral hygiene 
education from a dental hygienist at their bleeding disorder treatment center 
frequently to at every visit, are more likely to have regular preventive dental 
appointments and better oral hygiene habits than women with VWD that have not 
had oral hygiene education from a dental hygienist at their bleeding disorder 
treatment center. 
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Specific Aim 3: To determine the effectiveness of having a dental hygienist at 
bleeding disorder treatment centers to provide oral hygiene education to VWD 
patients. 
Null hypothesis (H0): Women with VWD who have had oral hygiene education 
from a dental hygienist at their bleeding disorder treatment center frequently to at 
every visit are as likely to have less gingival bleeding and less supragingival plaque 
as women with VWD that have not had oral hygiene education from a dental 
hygienist at their bleeding disorder treatment center. 
Alternative Hypothesis (H1): Women with VWD who have had oral hygiene 
education from a dental hygienist at their bleeding disorder treatment center 
frequently to at every visit are more likely to have less gingival bleeding and less 
supragingival plaque than women with VWD that have not had oral hygiene 
education from a dental hygienist at their bleeding disorder treatment center. 
1.4 Significance 
This clinical research sought to examine the correlation between VWD severity and 
gingival bleeding, assess the oral hygiene habits and dental care utilization in women 
with VWD, and address the effectiveness of having a dental hygienist to provide 
valuable oral hygiene education and instruction to patients with VWD. Ultimately, this 
information will give insight to the correlation between VWD and gingival bleeding when 
controlling for presence of plaque and other possible confounding variables. This will 
potentially improve the way oral hygiene education is delivered and stressed towards 
this population. 
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1.5 Thesis Overview 
Chapter II is the Review of the Literature and will guide the reader through the 
history of von Willebrand Disease (VWD), explore the current evidence relating VWD to 
oral health, and examine the correlation between supragingival plaque and gingival 
health. Chapter III reviews the Methods & Materials of this study, outlining each specific 
aim and how the data was analyzed. Chapter IV, Results, focuses on the statistical 
results of this study. Chapter V, Discussion, will include a comprehensive discussion of 
the study and in Chapter VI, the final conclusions will be revealed. 
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CHAPTER 2 
 
LITERATURE REVIEW 
 
2.1 von Willebrand Disease 
Von Willebrand Disease (VWD) is the most common hereditary coagulation 
abnormality, presenting in an estimated 1% of the population.1–3 Von Willebrand 
Disease can be caused by a genetic mutation in the von Willebrand Factor (VWF) gene 
or as a result of other medical conditions such as autoimmune disorders.4 Von 
Willebrand factor is an adhesive plasma protein that helps with blood clotting.2 
Normally, when bleeding occurs, platelets join together to stop the bleeding by forming 
a blood clot.2 In VWD, there is an interruption in this process.2 Depending on the type of 
VWD, there is either a qualitative or quantitative defect of von Willebrand Factor.1–4 A 
person without VWD has levels of VWF that are between 50 and 200 IU dL-1. There can 
also be a deficiency of factor VIII because VWF carries the factor VIII protein. There are 
three types of VWD.1–4, 9 
Von Willebrand Disease detection and identification has changed throughout 
history.9,10 In 1924, Erik Adolf von Willebrand identified what is now known to be VWD. 
He discovered VWD when a large family presented at his clinic with symptoms of 
severe mucosal bleeding. Clotting times were surprisingly normal, but the bleeding time 
lasted much longer than that of a normal individual. This showed Erik von Willebrand 
that this was a different bleeding disorder than hemophilia. After extensive laboratory 
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tests to check how the lack of the plasma factor influenced bleeding time, he was 
diverted by the fact that this lack of plasma factor did not affect coagulation time. 
Therefore, VWD was known in the 1960s as a combination of low factor VIII levels and 
another unknown plasma factor. Because of the lack of information available from the 
laboratory investigations, VWD was difficult to differentiate from other coagulation and 
platelet disorders.9,10 
Throughout time and many more laboratory investigations, scientists have come to 
the conclusion that VWD “is a bleeding disorder now recognized to be characterized by 
deficiency of, or defects in, an adhesive plasma protein called von Willebrand factor 
(VWF).”9 
Those with VWD have various symptoms mostly related to mucosal bleeding. 
Symptoms include epistaxis, gingival bleeding, menorrhagia, excessive bleeding from a 
cut, surgery or dental extraction, blood in the stool or urine, and easy bruising.1,3,4 
Eighty to ninety percent of women with VWD experience heavy menstrual bleeding, 
otherwise known as menorrhagia.2 Therefore, they are either treated with oral 
contraceptives or other birth control methods.2 Oral contraceptives are prescribed that 
either contain an estrogen (which reduces menstrual flow and likely increases VWF and 
Factor VIII levels) or progestin-only contraceptives, which also decrease bleeding.2 
Sometimes even a complete hysterectomy is recommended.2 Though many believe that 
oral contraceptive use leads to increased risk for periodontal disease, at the present 
time there is not enough research to support this idea.11,12 
Most people with VWD have a mild to moderate form and are only diagnosed after a 
significant bleeding episode or genetic testing due to family history.2,13 Diagnostic tests 
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include VWF antigen, VWF ristocetin cofactor activity, Factor VIII clotting, VWF 
multimers, and platelet function.1 There are different classifications of VWD: Type 1, 
Type 2A, Type 2B, Type 2M, Type 2N, and Type 3. Please see Table 1 for 
characteristics, prevalence, and bleeding propensity of each type of VWD. 
2.1.1 Classifying VWD 
Type 1 VWD 
Type 1 VWD is described as a partial quantitative deficiency of VWF. This affects 
about 75% of symptomatic VWD patients and causes mild to moderate bleeding 
propensity. Persons with Type 1 VWD typically have VWF levels of less than 20 IUdL-1. 
The genetic mutation for type 1 VWD is autosomal dominant.1 
Other studies describe that the genetic defect associated with most people with 
Type 1 VWD is not consistent, and that the levels can vary depending on environmental 
factors such as medications, exercise, pregnancy, and inflammation. Other genes can 
also influence the expression of the VWF gene.9,14 
Recent suggestions have been made that many of those with mild Type 1 VWD 
are actually false positives and do not have an identifiable VWF mutation. Many 
symptoms could overlap with normal individuals without coagulation abnormalities.9 
Some have even suggested that type 1 VWD be reserved for only those with markedly 
reduced levels, or a severe quantitative deficiency of VWF.14 
Type 2 VWD 
Type 2 VWD is described as a qualitative VWF defect. There are four subtypes: 
2A, 2B, 2M, and 2N. Almost all of the remaining 25% of VWD patients are classified as 
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having Type 2 VWD. In Type 2 VWD, bleeding propensity varies, but is usually 
moderate. The genetic mutation for type 2 VWD depends on the subtype. Type 2A and 
2M can be autosomal dominant or autosomal recessive. The types are noted with 
having VWF function than VWF antigen. The ratios between different laboratory values 
(Ristocetin Cofactor to VWF antigen and VWF:CB to VWF antigen) are also important in 
distinguishing these two subtypes from type 1 VWD. High molecular weight also plays 
an important role in distinguishing 2A from 2M.15 Type 2B is autosomal dominant and 
Type 2N is autosomal recessive.1 Type 2B is noted by an increased resemblance to a 
platelet known as GPIb. Type 2N is noted by a decreased binding affinity for factor 
VIII.15 In other words, factor VIII levels are reduced in those with type 2N. More details 
about each subtype of Type 2 VWD can be found within the Table 1 on page 10. 
Type 3 VWD 
Type 3 VWD is usually recognized as having an absence of VWF, whether by 
having a complete deficiency or undetectable levels of VWF (1-9 IU dL-1). This type is 
extremely rare, with a high bleeding propensity (severe bleeding). Type 3 VWD is 
autosomal recessive and is often misdiagnosed as hemophilia A.1,9 
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Table 1 VWD types and characteristics.9,10,16 
VWD type VWF level/defect Prevalence Bleeding propensity 
Genetic 
mutation 
1 
Usually <20 IUdL-1 
Quantitative 
Common 
About 80% of 
those with VWD 
have type 1 
Mild-moderate Autosomal dominant 
Type 2 Qualitative defect of VWF 
About 20% of 
those with VWD 
have type 2 
Moderate Depends on subtype 
2A 
Qualitative defect: 
loss of high 
molecular weight 
(HMW) 
Prevalence of 
subtypes 
unknown 
Moderate 
Autosomal 
dominant or 
autosomal 
recessive 
2B 
Qualitative defect: 
enhanced functional 
binding of VWF that 
leads to loss of 
HMW and mild 
thrombocytopenia 
Prevalence of 
subtypes 
unknown 
Moderate Autosomal dominant 
2M 
Qualitative defect: 
VWF dysfunction not 
associated with loss 
of HMW VWF 
Prevalence of 
subtypes 
unknown 
Moderate 
Autosomal 
dominant or 
autosomal 
recessive 
2N 
Qualitative defect: 
loss of VWF and 
Factor VIII binding 
Prevalence of 
subtypes 
unknown 
Moderate Autosomal recessive 
3 
Complete deficiency 
or undetectable 
levels (1-9 IUdL-1) 
Quantitative 
Extremely rare 
1-3:1,000,000 
High/Severe Autosomal recessive 
 
2.2 Inflammatory diseases of the periodontium 
 Research has shown that periodontitis and gingivitis are among the most 
common diseases worldwide.17 Gingivitis is more of a superficial inflammatory disease 
in that though bleeding of the gums may occur; the inflammation is not destructive 
towards the surrounding tissues such as the alveolar bone. Gingivitis can be reversed 
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with proper plaque removal. If left untreated, periodontitis can occur, which is 
characterized by alveolar bone loss that is irreversible. This can eventually lead to total 
loss of the tooth, in severe cases.18 Much evidence has pointed to the bacteria within 
biofilm, or dental plaque, as the main cause of inflammatory disorders of the 
periodontium.18–21,22 This assumption was gracefully demonstrated by the early studies 
of Löe and colleagues in the 1960s, using their experimental gingivitis model.22 
 In one study by Loe and colleagues, an attempt was made to introduce gingivitis 
to a group of healthy individuals by withholding oral hygiene practices. The goal of the 
study was to examine the changes in the bacteria within the plaque. Gingival Index and 
Plaque Index were used. Measurements were taken at the beginning of the study and 
instructions were given to avoid oral hygiene practices. Participants were evaluated at 
varying time intervals, where Gingival Index and Plaque Index values were taken again. 
When any inflammatory change was noted, the participants were instructed on oral 
hygiene methods. When the GI and PI values approached zero, the experiment was 
ended.22 
 This study found that at the end of the period where participants were not 
allowed to partake in oral hygiene practices, the PI value increased in mean from 0.43 
to 1.67, which is significant.  Every participant developed gingivitis at this phase as the 
mean GI value increased from 0.27 to 1.05. As soon as oral hygiene practices were 
allowed, the mean PI and GI dropped even below that of which it started at the 
beginning of the study. This study reveals that without proper oral hygiene practices, 
plaque buildup will increase rapidly and gingivitis will develop.22 
 12 
 
Another study that demonstrated the link between gingivitis and supragingival 
plaque was a study published in 2013 by Eberhard and colleagues. In this study, 
gingivitis was introduced experimentally in a group of young, healthy volunteers by 
terminating oral hygiene. When allowing the bacterial plaque deposits to accumulate on 
the tooth by terminating oral hygiene in one section of the mouth for 21 days, the 
gingiva was markedly affected. Values were significantly different on day 21 when 
examining Gingival Index, volume of gingival sulcus fluid, and bleeding on probing. 
“This inflammatory process was found to be almost completely reversible by appropriate 
dental hygiene.” This study shows the effects of supragingival plaque on the 
surrounding gingival tissues.18 
 This correlation between plaque and gingival health was also demonstrated in 
the study by Trombelli and colleagues, which was published in 2004. In this study, a 
split mouth design was used to keep the subject constant. This was also used to identify 
which subjects had different inflammatory responses to plaque deposits. This study also 
withdrew oral hygiene for 21 days. After 21 days, the changes in Gingival Index and 
bleeding were statistically significant.5 This study also demonstrated the link between 
supragingival plaque and gingival health. 
 A study by Lang and colleagues assessed the effects of plaque removal methods 
such as tooth brushing, flossing, and using a wooden toothpick to improve gingival 
health. In this study 32 healthy dental students were assigned to four groups. Group 1 
used the toothbrush to remove dental plaque twice a day, group 2 used the toothbrush 
every other day, group 3 used the toothbrush every three days, and group 4 used the 
toothbrush every four days. Each participant was instructed to use the same technique 
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for plaque removal and was to remove the plaque in its entirety. An examiner then 
checked to make sure plaque was removed by using disclosing solution. Only Groups 3 
and 4 developed gingivitis during this period of only brushing every 72 and 96 hours 
respectively even though Group 2 had similar amounts of plaque present. This led the 
researchers to believe that there are other factors that determine the plaque’s 
pathogenicity than accumulation alone. Overall, this study shows that gingivitis develops 
when someone does not remove plaque for over 48 hours. It is also evident that 
completely removing plaque every other day is more beneficial than attempting to do so 
numerous times a day inadequately.23 
2.3 VWD relation to oral health 
 Patients with VWD require special dental treatment accommodations,3 but 
because this bleeding disorder is rare, many dentists do not have experience in training 
patients with coagulation disorders, especially VWD.3,8,17,24 Therefore, an extensive 
amount of research recommends that any dental treatment be discussed with the 
patient as well as the patient’s hematologist.3,17,24,8 
 An article in the Journal of the Canadian Dental Association by Gupta and 
colleagues stresses the importance of the knowledge on treating patients with bleeding 
disorders.8 The importance of reviewing a patient’s medical history prior to treating the 
patient is stressed through dental and dental hygiene programs. Oral health care 
professionals are taught how systemic health relates to oral health and what medical 
conditions and medications warrant a modification in treatment. With that said dental 
professionals are also at the forefront of disease and can recognize many systemic 
conditions in which symptoms present intraorally. For instance, presence of petechiae, 
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intraoral hematomas, or excessive gingival bleeding should cause the dental 
professional to think of a possible underlying bleeding disorder. When a patient has a 
bleeding disorder, such as VWD, the patient’s physician should be contacted prior to 
any treatment to consider any treatment modifications.8 
 When symptoms of post-extraction bleeding and gingival bleeding in those with 
and without VWD were compared in 2011, those with VWD had a statistically significant 
amount of increased gingival bleeding than those without VWD in both males and 
females.13 These results are indicated in Tables 2 and 3. 
Table 2 Proportion of clinical bleeding history of  
46 female VWD patients and 47 controls13 
 
Table 3 Proportion of clinical bleeding history of  
19 male VWD patients and 16 controls13 
 
Research has shown that many patients with bleeding disorders have a fear of 
bleeding when removing plaque with brushing and flossing methods causing those with 
 Females with 
VWD (n=46) 
Females without 
VWD (n=47) 
Significance (p-
value) 
Prolonged 
bleeding post-
extraction 
20 (43%) 13 (28%) Not Significant 
Gingival Bleeding 21 (46%) 10 (21%) p-value=0.011 
 Males with 
VWD (n=19) 
Males without 
VWD (n=16) 
Significance (p-
value) 
Prolonged 
bleeding post-
extraction 
14 (88%) 4 (29%) p-value=0.005 
Gingival Bleeding 12 (63%) 4 (25%) p-value=0.027 
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bleeding disorders to generally have poorer oral hygiene than those without bleeding 
disorders.17,21  
There has not been a significant amount of impactful research that has examined 
the relationship between VWD and periodontal status. 17  For instance, a study 
conducted in 2011 by Ziebolz and colleagues sought to determine if having a congenital 
bleeding disorder had some effect on oral health and bone loss. An experimental group 
of individuals with coagulation disorders was compared to a control group of healthy 
patients. An examination was performed assessing oral hygiene and DMF-T, which 
calculates the number of decayed teeth, missing teeth, and filled teeth. Then 
periodontal bone loss was assessed with a panoramic x-ray. Results of the study 
showed that those with bleeding disorders actually had better oral hygiene than those 
healthy patients. Also, though there was a statistically significant difference in 
periodontal bone loss, the difference is not clinically significant since the value 
calculates out to be less than 1mm difference.17 
 As those with VWD bleed easily and have difficulty with blood clotting, these 
individuals are at a higher risk when receiving extensive dental treatment.17 In patients 
with bleeding disorders, there is a high risk of hematoma formation with local anesthesia 
injections, especially in highly vascular areas. Complications such as swelling, pain, 
respiratory obstruction, and even death from airway blockage can occur.8,25 
 This fatal occurrence happened to a man with hemophilia in a case study 
published in 1954 by Archer and Subrow. In this instance, an inferior alveolar nerve 
block was given to a man with hemophilia in order to restore/extract a tooth. The man 
was given two injections and could not get numb, so the procedure was terminated. 
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Two days later, the man was in the hospital with breathing difficulty. Later that evening, 
he was pronounced dead. From that instance, hematologists now advise patients with 
bleeding disorders to take their clotting factor prior to any injections in highly vascular 
areas.25 
 Urdaneta and colleagues conducted a study in 2008. This study, which took 
place at the University Hospital in Maracaibo, Venezuela, sought to examine the oral 
health and periodontal status of those with VWD who were treated. Forty patients were 
screened for this study. There was a control group of healthy individuals without 
bleeding disorders and a group of patients with VWD. Gingival Index (GI) and Simplified 
Oral Hygiene Index (SOHI) were used for this study. See Tables 4 and 5 for results of 
study.3 
 
Table 4 Comparison of Gingival Inflammation (GI) and the Simplified Oral Hygiene 
Index (SOHI) in patients with von Willebrand Disease and control group.3 
 
 
 
 
 
 
 
 von Willebrand Control Group P 
GI 0.70±0.40 
n=40 
0.88±0.68 
n=27 
P=0.17 
SOHI 1.7±0.80 
n=40 
0.76±0.55 
n=27 
P=0.0 
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Table 5 Degree of Gingival Inflammation (GI and the Simplified Oral Hygiene Index 
(SOHI) according to the variants of von Willebrand Disease.3 
 
Preventive dentistry and education is of the utmost importance for VWD patients 
to avoid any extensive dental procedures.8 Therefore, VWD patients consult with their 
hematologist at a bleeding disorder treatment center, where preventive oral health 
education may be discussed with the patients and a dental hygienist. 
The most recently found study was conducted by Weickert and colleagues, and 
was published in 2014 in the Journal of Clinical Periodontology. In an attempt to 
determine if gingival bleeding was indeed a symptom of patients with type 1 von 
Willebrand disease, Weickert evaluated hematological reports and subject’s periodontal 
measurements. This study found that those participants that were controls (without 
VWD) had more bleeding however this difference was not statistically significant. This 
study concluded that VWD is not associated with a more pronounced response to 
bacterial plaque and biofilm when looking at Gingival Bleeding Index (GBI) and Bleeding 
on Probing (BOP).26 Though this study concluded that gingival bleeding is not a direct 
  Gingival 
Index 
  SOHI  
VWD No 
Inflammation 
n=1 
Slight 
n=30 
Moderate 
n=9 
Adequate 
(0.0-1.2) 
n=15 
Acceptable 
(1.3-3.0) 
n=23 
Deficient 
(3.1-6.0) 
n=2 
Type 1 
n=37 
1 (2.5%) 29(72.5%) 7 (17.5%) 15(37.5%) 21 (52.5%) 1 (2.5%) 
Type 2A 
n=2 
0 1 (2.5%) 1 (2.5%) 0 1 (2.5%) 1 (2.5%) 
Type 3 
n=1 
0 0 1 (2.5%) 0 1 (2.5%) 0 
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symptom of type 1 VWD, there are limitations of the study. For instance, this study was 
limited to those with type 1 VWD. Scientific literature shows that many people with type 
1 VWD may be considered false positives since the VWF can fluctuate to levels that 
would be considered normal depending on many different factors such as exercise, 
pregnancy, etc.8,13 
All studies that have been reviewed have concluded that there is no evidence 
that those with VWD are at an increased risk for gingival bleeding or periodontal 
disease. With that said, the bleeding disorder does affect dental management. 
Preventative measures must be taken by educating the patient with VWD about risks of 
dental treatment and importance of adequate oral hygiene. Multidisciplinary teamwork 
must also be considered to be certain that those patients with VWD are treated safely 
and effectively. 
 
 
 
 
 
 
 
 
 
 19 
 
CHAPTER 3 
 
METHODS AND MATERIALS 
 
3.1 Study Design 
 This study sought to examine the oral hygiene and gingival bleeding sites of 
women with von Willebrand Disease (VWD) to determine the correlation between VWD 
and gingival bleeding. Though a longitudinal study design may have provided more 
evidence about this population, plaque accumulation, and gingival bleeding over time, a 
cross-sectional study design was chosen due to time limitations and resources. A cross-
sectional study was also chosen to provide descriptive data about this population in 
order to control for possible confounding variables. This study used clinical and survey 
components to investigate this relationship. 
3.2 Source Population 
The source population for this study was adult female patients with von 
Willebrand Disease (VWD) attending bleeding disorder treatment centers at either 
University of Michigan Hemophilia and Coagulation Disorders in Ann Arbor, Michigan or 
Michigan State University Center for Bleeding and Clotting Disorders in East Lansing, 
Michigan.  
3.3 Participant Recruitment Strategy 
Patients attending bleeding disorder treatment centers at University of Michigan 
Hemophilia and Coagulation Disorders in Ann Arbor or Michigan State University Center 
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for Bleeding and Clotting Disorders in East Lansing were identified through chart review 
as to their eligibility for the study. Subjects presented for their annual or biannual 
physical examination at the given bleeding disorder treatment center. Upon signing into 
the center, they were approached by the examiner and asked if they had an interest in 
participating in the study. The study procedures were explained in detail. If the subject 
was interested in participating in the study, further participant eligibility was then 
determined. Individuals who completed the study were compensated ten dollars cash 
for their time. 
3.4 Eligibility Criteria 
 Adult women, over the age of 18 with von Willebrand Disease (VWD), were 
eligible to participate in the study if they had at least 12 teeth present and were capable 
of consenting and self-administering the survey component of the study. Subjects were 
excluded if they were under the age of 18, had uncontrolled diabetes, had significant 
psychiatric illness/social situations that would interfere with the completion of the 
survey, or were taking medications that cause gingival enlargement such as anti-
convulsants, calcium-channel blockers (nifidipine, amolodipine, verapamil), 
cyclosporine, or anti-coagulants.  
3.5 Data Collection 
This study examined the effects of VWD on gingival bleeding when controlling for 
presence of plaque. The study had both a clinical and survey component to assess 
gingival bleeding, plaque removal, oral hygiene habits, and dental care utilization. This 
study did not administer any treatments or drugs to participants. Informed consent was 
 21 
 
obtained prior to giving the questionnaire, extracting data from the patient’s medical 
chart, and collecting clinical data.  
 3.5.1 Questionnaire Data Collection 
Questionnaire: After obtaining a signature for consent, the survey/questionnaire 
portion of the study was given to the subject to fill out. This survey took about 5-10 
minutes to complete and covered information regarding patient demographics, oral 
hygiene habits, dental care utilization, perceived frequency of gingival bleeding, and 
behavioral factors. The questionnaire was created based on current literature that either 
suggested relationships between VWD and some of the possible confounding factors or 
current literature that did not control for other possible confounding variables that have 
been shown in literature to relate to gingival bleeding. 
Demographic information included which race/ethnicity the participant identified 
with best, age, education (less than high school, high school/some college, or college 
degree), and employment status (full-time, part-time, or none). Questions that covered 
oral hygiene habits included frequency of tooth brushing, flossing, and the use of other 
oral hygiene aids. Dental care utilization questions asked if there was dental insurance 
present, how often the participant visits the dentist (less than yearly, once a year, or 
more than once a year), and if the participant ever felt discriminated against due to her 
bleeding disorder (1 = yes, 0 = no).  The questionnaire also asked how often the 
participant experiences gingival bleeding (less than once a month, once a month, or 
more than once a month). Behavioral factors assessed if the participant smokes 
cigarettes/cigars/pipes and drinks alcohol and how often.  
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Open-ended questions allowed for the participant to explain how or why she has felt 
discriminated against for having a bleeding disorder, why she has avoided the dentist in 
the past, and to explain how she was refused treatment. 
The questionnaire was completed just before the oral examination was performed. 
Confidentiality was secured by assigning a patient identification number. Only the thesis 
committee has access to this information. Please see Appendix A for questionnaire.  
Chart Review: VWD related data including type, von Willebrand factor (VWF) levels 
(mild, moderate, or severe), details of method of diagnosis, medical conditions, and 
medications was collected from the patient’s medical record and documented on chart 
data sheet. See Appendix B for chart data sheet. 
3.5.2 Clinical Data Collection 
 Oral Examinations: All oral examinations were performed at the time of the 
participant’s appointment at one of the two bleeding disorder clinics: University of 
Michigan Hemophilia and Coagulation Disorders in Ann Arbor or Michigan State 
University Center for Bleeding and Clotting Disorders in East Lansing. A brief oral exam 
was performed on each patient to assess gingival bleeding and oral hygiene. Presence 
or absence of plaque on the mesiobuccal, buccal, distobuccal, mesiolingual, lingual, 
and distolingual surfaces of the six Ramfjord teeth was also recorded as 0 or 1 (0=no 
plaque, 1=plaque) on the Oral Examination Form (Appendix C). Carter and Barnes 
Gingival Bleeding Index (GBI) was used with a C-wrap floss technique to detect 
presence or absence of bleeding of the gingiva mesially and distally to the six Ramfjord 
teeth (tooth numbers 3, 9, 12, 19, 25, 28).18 The same coding was used for bleeding (0, 
1) and was also recorded on the Oral Examination Form. When one or more of the six 
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Ramfjord teeth was missing, the most posterior adjacent tooth was used that had a 
tooth in contact mesially and distally. The two examiners flossed, recorded presence or 
absence of plaque, and recorded presence or absence of bleeding upon flossing. Both 
supragingival plaque and gingival bleeding will be coded as 0-no bleeding/plaque and 1-
bleeding/plaque.  
3.6 Examiner training and calibration session:  
Prior to enrollment of subjects, examiners completed a calibration exercise for 
both clinical parameters. The aims of the calibration session were to train all clinical 
examiners in the measurements that were taken and to determine the level of inter-
examiner agreement looking at gingival bleeding and presence of supragingival plaque. 
One subject was recruited to participate in calibration exercises. Since there was 100% 
agreement between examiners on surfaces with plaque and gingival bleeding, the 
calibration session did not need to be repeated. The subject was made aware of the 
details of the study and informed consent was obtained. 
3.7 Statistical Analyses 
 The distributions of all variables were generated and examined for outliers and 
the need for possible transformation prior to analysis. SPSS was the statistical software 
used for data analysis. All analyses will use a statistical significance at the conventional 
level of p=0.05.  
 Aim 1: To determine the relationship between gingival bleeding and VWF levels 
while controlling for the presence of supragingival plaque. A paired samples t- test was 
used to determine if presence of bleeding is dependent on plaque presence. Linear 
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regression was used to adjust for possible confounding variables such as VWD 
type/severity, oral hygiene habits, or dental utilization. 
Aim 2: To determine oral hygiene habits and dental care utilization in those with 
VWD. Descriptive statistics were calculated for all variables. Chi-square models and 
linear and logistic regression to analyze the data collected from the 
survey/questionnaire component of the study depending on whether the variables were 
continuous or categorical. 
Aim 3: To determine the effectiveness of having a dental hygienist at bleeding 
disorder clinics to provide oral hygiene education and instruction. We tested the 
hypothesis that receiving oral hygiene instruction from a dental hygienist at the bleeding 
disorder clinic is associated with less gingival bleeding and less plaque. For each 
outcome, linear regression was used to determine if having a dental hygienist present is 
associated with each outcome. Each test provided an odds-ratio and 95% confidence 
interval. Linear and logistic regression were used to adjust for possible confounding 
variables such as severity of VWD, age, race, education level, and dental utilization. 
To determine the relationship between plaque and gingival bleeding, each site in 
the mouth had one of four possible outcomes. A site could have plaque with bleeding 
(YPYB), plaque with no bleeding (YPNB), no plaque with bleeding (NPYB), or no plaque 
with no bleeding (NPNB). 
                     Bleeding 
 
Plaque 
 Yes No 
Yes YPYB YPNB 
No NPYB NPNB 
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3.8 Sample Size Estimation:  
The study was designed to achieve at least a 45% difference in the occurrence of 
gingival bleeding when plaque is present, out of the twelve sites measured for this 
study. A power calculation was generated and it was determined that a sample size of 
38 women would provide us with at least 80% power that there would be a 45% or 
greater incidence of gingival bleeding when plaque is present. A study by Pizzo et al 
was used to make this sample size calculation. In this study, the effects of hormone 
replacement therapy on periodontal status were looked at, where a significant difference 
was found in gingival bleeding between the two groups.27 
3.9 Quality Control and Data Management: 
 Data was entered into Excel Spreadsheet. This document is password protective. 
Each subject was identified in the document with a unique patient identification number. 
All surveys were kept in a lockbox. Only those on the thesis committee have had access 
to these documents. After being entered into Excel, data was checked for errors or 
missing items. The data was then transferred to the statistical program, SPSS for data 
analysis. This program was also password protective. 
3.10 Protection of Human Subjects: 
IRB approval was sought at University of Michigan and Michigan State University 
prior to any recruitment or enrollment for the study. See Appendix D for the IRB 
approval letter. The source population for this study was adult female patients with VWD 
attending clinics at the University of Michigan Hemophilia and Coagulation Disorders in 
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Ann Arbor, Michigan or Michigan State University Center for Bleeding and Clotting 
Disorders in East Lansing, Michigan. Women in this study were above 18 years of age. 
After determining patient eligibility, the informed consent form was reviewed and 
given to each individual to sign. See Appendix E for the Informed Consent document. 
The informed consent form reviewed in layman’s terms, the purpose of the proposed 
study, benefits to the patient, time required to participate, possible risks and 
discomforts, name of the investigator, right of the patient to accept or refuse treatment 
and to withdraw at any time, and a statement of patient confidentiality.  
The risk of complications was very low since the only measurements taken were 
with standard floss technique and using the probe supragingivally. Other data was 
collected with the survey and from the existing medical record. 
Breach of confidentiality of personal health information was at a low risk since we 
used patient id numbers instead of names. A breach of confidentiality of personal health 
information did not occur. If this event would have occurred, the IRB would have been 
notified and routine procedures would have been taken to solve the incident.  
 
Serious Adverse Event (SAE) Reporting 
To the thesis committee’s knowledge, an SAE did not occur. However, should 
any SAE occur from this point forward, which is very unlikely, the IRB will be notified as 
soon as possible and within 7 days from when the investigator is first informed. Protocol 
will still be reviewed on a weekly basis centering on potential safety issues. 
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CHAPTER 4 
 
RESULTS 
 
4.1 Patient Recruitment 
 A sample size of 38 adult women with VWD was desired for this study. At the 
University of Michigan Hemophilia and Coagulation Disorders in Ann Arbor, Michigan 
and Michigan State University Center for Bleeding and Clotting Disorders in East 
Lansing, Michigan, a total of 45 women were approached to participate in this study. Of 
the 45 women approached at the given bleeding disorder treatment centers, 44 agreed 
to participate in the study. The one individual that did not participate did not feel 
comfortable with the clinical portion of the exam therefore her survey and chart data 
was discarded. 
4.2 Descriptive Statistics 
 Descriptive statistics for the 44 study participants are provided in Table 4. Of the 
44 women that participated in this study, 20 (45.5%) women attend the University of 
Michigan Hemophilia and Coagulation Disorders in Ann Arbor, MI and 24 (54.5%) 
women attend the Michigan State University Center for Bleeding and Clotting Disorders 
in East Lansing, MI.  
The mean age of women who participated in the study was 39.6 years 
(SD=16.00599). Caucasians were the largest racial/ethnic category to make up the 
sampled population, comprising 77.3% (n=34) of the sample that responded to this 
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question. Approximately 9.1% (n=4) women identified as African American, 4.5% (n=2) 
identified with Hispanic, and 4.5% (n=2) identified as “Other”.  
Most participants, 50.0% (n=22), had an education level of High School and/or 
Some College, while 21 others have a college degree (47.7%). The majority of 
participants stated no employment, comprising 50% of the sample (n=22) yet 72.7% of 
participants had dental insurance (n=32). Most of the women who participated in the 
study did not partake in alcohol consumption, 63.4%, or tobacco use, 95.1%.  
Most of the participants, 65%, stated that oral hygiene is reviewed at their 
bleeding disorder treatment center appointments frequently or at every visit (n=26). Only 
15% of individuals stated that oral hygiene was never reviewed at these appointments 
(n=6). Of those surveyed, 57.5% of participants stated that a dental hygienist at their 
treatment center is the primary provider that reviews oral hygiene education (n=23), 
while 12.5% (n=5) stated that no one reviews oral hygiene education with them. Others 
receive oral hygiene education from a hematologist (2.5%, n=1), a dental hygienist or 
dentist outside of the treatment center (25%, n=10), or by another source (2.5%, n=1). 
 The majority, 73.8% (n=31) of the participants perceive the health of their gums 
to be in fair-good condition, while 23.8% (n=10) perceive them to be very good-excellent 
and 2.4% (n=1) in poor condition. The perception these individuals had of health of their 
teeth is slightly different with 76.2% (n=32) believing they were in fair-good condition, 
16.7% (n=7) in very good-excellent condition, and 7.1% (n=3) in poor condition. Though 
83.3% (n=35) believed the importance of oral health to be very important, 16.7% (n=5) 
of individuals surveyed still believe oral health is only somewhat important.  
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 Of the women that participated, 50% (n=20) have experienced a gum bleed more 
than twice a month. Those that have experienced a gum bleed less than once a month 
make up 27.5% (n=11) of those surveyed.  
When brushing, 38.1% (n=16) of those surveyed have experienced bleeding of 
the gums fairly often-very often, 57.1% (n=24) have experienced bleeding of the gums 
hardly ever-on occasion, and 4.8% (n=2) have never experience bleeding of the gums 
when brushing. This data is presented in Figure 5. 
When flossing, 52.9% (n=18) have experienced bleeding of the gums fairly often-
very often, 38.2% (n=13) have experienced bleeding with flossing hardly ever-on 
occasion, and only 8.8% (n=3) have never experienced bleeding with flossing. This data 
is presented in Figure 5. 
 Regarding oral hygiene habits, 74.3% (n=26) of women brush more than once a 
day, 20% (n=5) brush only once a day, and 5.7% (n=2) brush less than once a day. The 
majority of women surveyed floss 1-6 times a week, 37.1% (n=13), 34.3% (n=12) floss 
less than once a week, and 28.6% (n=10) floss at least once a day. This data is 
presented in Figures 2 and 3. The majority of women, 92.9% (n=39) use some other 
type of oral hygiene aid such as mouthwash, WaterPik, interdental brush, toothpick, etc. 
 Though 73.8% of the women surveyed have dental insurance, only 56.1% (n=23) 
had a dental appointment within the last six months. About 14.6% (n=6) had a dental 
appointment between six to twelve months ago, and for 29.3% (n=12) of women, it has 
been more than a year since their last appointment with a dentist.  
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While 40.5% (n=17) of women surveyed have avoided seeing a dentist, the most 
common reason for avoiding a dentist was related to not having insurance or financial 
reasons, which 27.6% (n=10) of women could relate to. Only 18.4% (n=8) of individuals 
surveyed listed reasons related to being nervous about treatment or not finding a dentist 
that they felt comfortable going to.  
Most women, 85.7% (n=36), stated that they have never been refused treatment 
because of the possibility of bleeding disorder complications. However, 14.3% (n=6) of 
those surveyed have been refused treatment due to reasons such as “high danger of 
bleeding”, “refused to see because I had a blood disorder”, and “my bleeding time was 
15 minutes”.  
While most women stated that they had never felt any bias from any oral health 
care provider that they thought was due to their bleeding disorder, 8.8% (n=3) of the 
women stated that they had felt a bias from an oral health care provider due to high 
bleeding risk and the dentist not wanting to treat them. One woman even stated that it 
was tough at first to find a dentist who wasn’t nervous about the liability of a bleeding 
disorder when she was a child. 
The majority, 74.42%, of the women who participated in this study had type 1 
VWD. Those who had type 2 VWD comprised about 9.30%, one of which had type 2N, 
another who had type 2A, and two individuals whose chart did not specify the subtype. 
Two individuals had type 3 VWD, comprising 4.65% of the women who participated in 
this study. 
For the purpose of analyzing this data, The variable “Severity” was broken into 
three categories depending on the individual’s last von Willebrand factor level reading 
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(1=less than or equal to 30, 2=31-60, 3=higher than 60). For those women who 
participated in this study, 16.3% of them had a VWF level of less than or equal to 30, 
14% had a VWF level between 31 and 60, and 53.5% had a VWF level of more than 60. 
Data was missing on 7 individuals because lab values for VWF were not within their 
medical charts. 
4.3 Clinical Measures  
The clinical component of the study consisted of evaluating the mesial and distal 
surfaces on each of the six Ramfjord teeth for presence of supragingival plaque and 
bleeding with flossing totaling twelve sites in each mouth. On average, women had 7.34 
(SD=4.46) sites of plaque and 2.41 (SD=2.55) sites of bleeding.  Of the women who 
participated, 22.7% (n=10) had 12 sites of plaque and 36.4% (n=16) had no sites of 
bleeding. Please see Table 6 and 7 for a representation of the clinical data. 
 Data shows that on average, 44.33% (n=5.32) of the twelve sites had plaque, but 
no bleeding, 35.58% (n=4.27) of the twelve sites had no plaque and no bleeding, 
16.25% (n=1.95) of the twelve sites had plaque with bleeding, and only 3.75% (n=0.45) 
of the twelve sites had no plaque with bleeding. This data is presented in Table 8. 
4.4 Examining the Relationship Between Gingival Bleeding and Dental Plaque 
Data was collected on twelve sites in each individual’s mouth. Having four 
possible outcomes per site (YPYB, YPNB, NPNB, NPYB), gives us six possible 
combinations when analyzing the differences between possible outcomes. Since this 
study sought to determine if presence of gingival bleeding was more related to the 
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presence of plaque or having von Willebrand disease, only four of these combinations 
related to this study. 
A paired samples t-test was used for each of these possible combinations to 
determine if the differences were statistically significant. See Table 9 for the paired 
samples t-test for each possible combination of averages.  
The relationship between the surfaces with plaque and bleeding (YPYB) and no 
plaque with bleeding (NPYB) was explored. The average number of sites a person had 
with plaque and bleeding was 1.9767 (16.47%). The average number of sites a person 
had with no plaque, but still bleeding was 0.4186 (3.49%). The difference between the 
means was 1.5581, or 12.98%. This difference in means is statistically significant 
(p=.000). 
The relationship between the surfaces with plaque and bleeding (YPYB) and 
plaque with no bleeding (YPNB) was also explored. The average number of sites a 
person had with plaque and bleeding was 1.9767 (16.47%). The average number of 
sites a person had with plaque and no bleeding was 5.4419 (45.35%). The difference 
between the means was 3.4652, or 28.88%. This difference in means is statistically 
significant (p=.000). 
The relationship between the surfaces with plaque and no bleeding (YPNB) and 
no plaque with bleeding (NPYB) indicated that the average number of sites a person 
had with plaque and no bleeding 5.4419 (43.35%). The average number of sites a 
person had with no plaque, but still bleeding was 0.4186 (3.49%), therefore the 
difference between the means was 5.0233, or 41.86%. This difference in means is 
statistically significant (p=.000). 
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The relationship between the surfaces with no plaque and no bleeding (NPNB) 
and no plaque with bleeding (NPYB) was also explored. The average number of sites a 
person had with no plaque and no bleeding was 4.1628 (34.69%). The average number 
of sites a person had with no plaque, but still bleeding was 0.4186 (3.49%). The 
difference between the means was 3.7422, or 31.20%. This difference in means is 
statistically significant (p=.000). 
4.5 VWF levels and gingival bleeding 
  Linear regression was used to determine the relationship between plaque and 
mean number of sites of gingival bleeding. In addition, potential confounding variables 
for each specific aim were examined. Each linear regression analysis, as well as the 
results, is described below. 
The number of gingival bleeding sites was used as a dependent variable in an 
unadjusted linear regression analysis. Von Willebrand factor level was the independent 
variable and was tested with gingival bleeding for possible correlation, independent of 
presence of supragingival plaque. The average number of sites with bleeding for an 
individual with a VWF of less than 30 is 1.807. The average number of sites with 
bleeding for an individual with VWF level between 30 and 60 is 2.214. The average 
number of sites with bleeding for an individual with a VWF of greater than 60 is 2.621. 
The results were insignificant (p=.465).  
Each paired samples t-test that was performed was also analyzed with linear 
regression to control for the level of von Willebrand Factor (VWF). The VWF level was 
divided up into three categories based on the National Heart, Lung, and Blood Institute 
and National Hemophilia Foundation information. 
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When using linear regression to determine if VWF level had an effect on the 
relationship between all four possible outcomes, linear regression showed that VWF 
level was not a contributing factor (p>.05). 
The first test analyzed the difference of means between YPYB and NPYB. When 
controlling for severity, the difference between those sites that had plaque with bleeding 
and those that did not have plaque, but still had bleeding is no longer significant 
(p=.450). The second test analyzed the difference of means between YPYB and YPNB. 
When controlling for severity, the difference between those sites that had plaque with 
bleeding and those that did not have plaque, but still had bleeding is no longer 
significant (p=.816).  The third test analyzed the difference of means between YPNB 
and NPYB. When controlling for severity, the difference between those sites that had 
plaque with bleeding and those that did not have plaque, but still had bleeding is no 
longer significant (p=.532). The fourth test analyzed the difference of means between 
NPNB and NPYB. When controlling for severity, the difference between those sites that 
had plaque with bleeding and those that did not have plaque, but still had bleeding is no 
longer significant (p=.234).  
4.5.1 Socio-demographic and behavioral factors and gingival bleeding 
Since there was not a significant relationship between VWF levels and mean 
gingival bleeding sites, other confounding variables were tested using multiple linear 
regression. Age seemed to have a positive effect on the amount of gingival bleeding, 
but this relationship was not significant. When controlling for last dental visit, the 
relationship between the variables was significant (p=0.04). This model can be found in 
Table 10. 
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When controlling for patient perception of bleeding upon flossing during at home 
oral hygiene, it was found to have a significant effect on the number of surfaces that had 
gingival bleeding when plaque was present. For those who state they bleed with 
flossing fairly often to very often, they would be expected to have 22.5% sites with 
plaque and bleeding, but for those who state they never bleed with flossing, they would 
be expected to have only 1.64% sites with plaque and bleeding. This difference in 
percentage of sites with plaque and bleeding is statistically significant (p=.024). 
When controlling for last visit to the dentist, it was found that this significantly 
effected which surfaces had bleeding when plaque is present. For instance, if someone 
had been to the dentist less than 6 months ago, on average we would expect to see 
11.992% of sites with bleeding and plaque. For someone who hasn’t been to the dentist 
in over one year, we would expect about 26.46% of sites to have bleeding and plaque. 
This difference is statistically significant (p=.031). 
Bleeding upon brushing also significantly affects the amount of gingival bleeding 
expected at an individual site. For instance, for an individual who states she has 
bleeding with brushing fairly to very often, we would expect to see about 34.47% of sites 
have gingival bleeding. In someone who only complains of bleeding with brushing 
hardly ever to on occasion, we would only expect to see gingival bleeding on 13.43% of 
sites. This relationship is statistically significant (p=.000) 
4.5.2 Effectiveness of providing oral hygiene education for those with bleeding 
disorders 
When examining the effectiveness of providing oral hygiene education at 
bleeding disorder treatment centers, both effect on plaque and gingival bleeding were 
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assessed as outcomes. The average number of plaque sites per person was examined 
while controlling for how often a provider at the bleeding disorder treatment center 
provides oral hygiene instruction. In those women who stated that no one ever reviews 
oral hygiene education with them at their treatment center, we expect to see plaque 
present on 10.5 out of the 12 sites measured. In those women who stated that someone 
reviews oral hygiene education frequently to at every visit, we would expect to see 
plaque present on 6.8 out of the 12 sites measured. This difference in plaque presence 
is statistically significant (p=0.03). This data is displayed in Figure 13. 
When controlling for whom provides oral hygiene education, we expect to see 7 
sites out of 12 with plaque in those who receive oral hygiene education from their dental 
hygienist at their treatment center. For those that receive oral hygiene education from a 
dental hygienist outside of their treatment center, we expect to see about 7.75 of sites 
out of 12 with plaque. In those that do not receive oral hygiene education at all, we 
expect to see an average of 10 out of 12 sites with plaque present. Though this 
relationship is not statistically significant, it is clinically significant. This is especially 
evident when examining average sites with gingival bleeding. In those who do not 
receive oral hygiene education, we see an average of 4.676 sites out of 12 with gingival 
bleeding. In those who receive oral hygiene education from a dental hygienist at their 
treatment center, we expect to see only 2.478 sites out of 12 with gingival bleeding. This 
difference is statistically significant (p=0.03).This data is displayed in Figure 14. 
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Chapter 5 
 
Discussion 
To the author’s knowledge, this was the first study to assess the relationship between 
VWD, plaque accumulation, and gingival bleeding 
5.1 Study Objective and Aims 
The goal of this study was to examine the relationship between gingival bleeding 
and oral hygiene in women with von Willebrand Disease (VWD). To accomplish this 
goal, this study had three specific aims. Below, each aim is focused on individually. In 
addition, the syntheses of the research findings for each specific aim are shared. 
5.2 Aim 1: Synthesis of Research Findings 
Specific Aim 1 was to determine if gingival bleeding in women with VWD was 
related to the presence of supragingival plaque even when controlling for VWF levels. 
Numerous studies have shown the relationship between gingival bleeding and 
supragingival plaque. One study that was completed earlier this year examined the 
amount of gingival bleeding in those participants with VWD compared with the amount 
of gingival bleeding in those participants without VWD. This study determined that 
gingival bleeding was not considered a symptom in those with VWD considering the 
insignificant results. 
For this particular study, severity of the bleeding disorder was controlled for in the 
analysis to see if there was a pattern between more bleeding sites and decreased von 
Willebrand Factor (VWF).The current research shows some fluctuation of VWF 
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throughout life in events such as hormonal contraceptive use, time during menstrual 
cycle, pregnancy, age, and hormonal contraceptive use. Therefore, severity was ranked 
according to the patient’s last laboratory value of VWF. These values were also 
examined because even though an individual was diagnosed with a type of VWD, the 
severity or subtype was not always identified in the patient’s chart. 
The relationship between VWF level and gingival bleeding sites was first tested 
with linear regression. This relationship was not significant, so other confounding 
variables were controlled for. Age and last dental appointment seemed to have more of 
an effect on the amount of gingival bleeding noted on each patient. Though not a 
statistically significant relationship, interestingly, as age increased the amount of 
gingival bleeding decreased. When testing the effect on the participant’s last dental visit, 
having a dental visit within the past six months had a protective effect on the amount of 
bleeding noted.  
When comparing the means of the four possible outcomes to see if plaque had 
an effect on the amount of gingival bleeding, four analyses revealed interesting 
information. The first analysis was used to determine the difference in means between 
YPYB and NPYB. With the paired samples t-test, the difference in means was 
statistically significant. For a woman with VWD, it is expected that if a site in the mouth 
has bleeding, it is significantly more likely to have plaque. When linear regression was 
used to control for VWF level, the analysis showed that VWF level has no effect on this 
difference in means. This implies that for women with VWD, gingival bleeding is more 
likely caused by presence of supragingival plaque than by the level of VWF. 
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The second analysis was used to determine the difference in means between 
YPYB and YPNB. With the paired samples t-test, the difference in means was 
statistically significant. Therefore, for a woman with VWD, it is expected that if a site in 
the mouth has plaque present, it is significantly less likely to have gingival bleeding than 
to have gingival bleeding when a gentle C-wrap floss technique was used. When linear 
regression was used to control for VWF level, the analysis showed that VWF has no 
effect on this difference in means. Conclusions can be made that when performing a 
gentle C-wrap floss technique, even in those with low VWF levels, it can be performed 
in a manner that does not cause gingival bleeding. These findings can be shared with  
women with VWD in an effort to increase their awareness that flossing without causing 
bleeding is, in fact, possible. 
The third analysis that was completed compared the difference in means 
between NPYB and YPNB. With the paired samples t-test, the difference in means was 
statistically significant. Therefore, for a woman with VWD, it is expected that significantly 
more sites in the mouth on average will have no bleeding even with plaque present than 
bleeding without plaque present. Since NPYB could potentially be indicative of VWD 
having an effect on gingival bleeding regardless of plaque presence, these results show 
that the exact opposite, which could be considered as more of a state of health (YPNB) 
is more likely even in someone with VWD. 
The fourth analysis that was completed compared the difference in means 
between NPYB and NPNB. With the paired samples t-test, the difference in means was 
statistically significant. When testing to see if VWF level was considered a confounding 
variable, linear regression showed that VWF level has no effect on this difference in 
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means. Therefore, in a women with VWD, it is expected that those sites in the mouth 
that do not have plaque, a significantly lower percent will have bleeding than not 
bleeding, even when controlling for level of VWF. This implies, again, that VWF level 
has no effect on the number of sites in the mouth that have gingival bleeding. See Table 
9 for each outcome relationship’s paired samples t-test and linear regression results. 
When assessing the relationship between presence of gingival bleeding and 
VWF level, data shows that the relationship is not statistically significant. Though the 
relationship is not statistically significant, the mean number of sites with gingival 
bleeding was actually higher in the group of individuals with less of a VWF deficiency. 
This indicates that in those with lower VWF levels, less gingival bleeding is actually 
expected. This is presented in Table 9. 
In summary, the aforementioned analyses indicate that gingival bleeding may be 
more related to presence of gingival plaque than being related to and considered as a 
symptom of VWD. In fact, the majority of sites in the mouths of this population had 
plaque presence without bleeding. This study shows that there is 95% confidence that 
among women with VWD, the average number of sites with gingival bleeding is 
between 1.6032 and 3.1875 out of 12 sites measured. The fact that more sites had no 
bleeding even with presence of plaque indicates that women with VWD can perform 
gentle C-wrap technique without causing gingival bleeding. Confidently expressing this 
to patients with VWD can assure them that proper oral hygiene can be performed 
effectively without causing excessive, if any, gingival bleeding. 
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5.3 Aim 2: Synthesis of Research Findings 
 The second aim of this study was to determine the oral hygiene habits and dental 
care utilization in women with von Willebrand Disease (VWD). Results show that the 
majority of the women in this study have dental insurance and over 80% believe the 
importance of oral health to be very important, but for almost 30% of the women, their 
last visit to the dentist was over a year ago. When linear regression was used to 
determine if insurance had an effect on last DDS visit, this relationship was deemed to 
be insignificant (p=.100) With that said, when “who provides oral hygiene” was taken 
into consideration, there was a statistically significant relationship. For those who 
receive oral hygiene education from their dental hygienist whether at a bleeding 
disorder treatment center or at a private practice dental office, the average time since 
last DDS visit was significantly closer to being 6 months ago than those individuals who 
receive oral hygiene education from their hematologist or not at all. 
 Though the majority of the women surveyed stated they have never avoided 
seeing the dentist, 40.5% of these women stated that they have. Even though the most 
common reason for avoidance was related to financial issues or lack of insurance, 
18.4% of these women could relate to being nervous about treatment. Some women 
even stated that they have been refused treatment for having a bleeding disorder and 
even felt a bias when interacting with an oral health care provider in the past. When 
controlling for noted anxiety and examining if this had an effect on last DDS visit, the 
relationship was not significant (p=.461).  
 When comparing oral hygiene habits of the women that participated in this study, 
there is no relationship between oral hygiene habits at home and perceived gingival 
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bleeding with brushing, flossing, or using other oral hygiene products such as 
mouthwash, WaterPik, etc. However, the difference in gingival bleeding for someone 
who flosses at least once a day and someone that never flosses is clinically significant. 
Unexpectedly, the number of sites of bleeding increased the more frequently the 
participants stated that they floss. It is possible that the incorrect floss technique is 
being used at home since the majority of surfaces had plaque with no bleeding during 
the clinical portion of the study. 
5.4 Aim 3: Synthesis of Research Findings 
 When examining the amount of gingival bleeding and determining confounding 
variables related to delivering oral hygiene instruction, linear regression was used. Two 
questions on the patient survey touched on providing oral hygiene education at bleeding 
disorder treatment centers. The first question asked, “How often does someone at your 
bleeding disorder treatment center discuss oral health with you?” The second question 
asked, “Who usually discusses the importance of oral health with you?” Both of these 
variables were used to assess Specific Aim 3, which analyzes the effectiveness of 
having a dental hygienist at bleeding disorder treatment centers to provide oral hygiene 
education to patients with VWD. 
 Results showed that there is a significant difference in both presence of plaque 
and gingival bleeding when controlling for the two aforementioned variables. This 
implies that educating patients on oral health and oral hygiene instruction can lead to 
patients with bleeding disorders having better oral hygiene, therefore less gingival 
bleeding. This relationship is statistically significant in two of the three linear regression 
tests that were analyzed.  
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5.5 Limitations and Recommendations 
Though this study was used as a pilot to generate data about a small population 
of women with von Willebrand Disease (VWD) in hopes to gain the results and 
conclusions for a larger study in the future, there were many limitations to this study.  
5.5.1 Limitations of Study Design 
This study was a cross-sectional study, which allowed only for a snapshot in time 
analysis. As such, no determinations on causality can be made. Conducting a 
longitudinal study would have allowed for further observation as well as the correct 
temporal sequence in this population. However, in this study, the patients were 
approached at their bleeding disorder treatment centers, consented, and the study was 
immediately completed. Therefore, the patients were unable to prepare for the exam by 
perhaps brushing and/or flossing their teeth and gave a “real life” or every day view into 
the patients’ regular home care regimens. 
The one major limitation of this study was the lack of a control group. Having a 
control group would have shown the relationship between those with VWD and those 
without VWD. The reason for not having a control group was related to funding and time 
constraints. Since this study was completed as a part of the Master of Science in Dental 
Hygiene (MSDH) program and the principal investigator was on track to graduate in two 
years, time was limited. 
In an effort to strengthen our findings, we examined the National Health and 
Nutrition Examination Survey (NHANES) data on the prevalence of gingivitis in women 
between the ages of 17 and 51 was obtained from a study by Taichman and 
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colleagues.11 This data was used as a control group to compare the prevalence of 
gingivitis between women with and without VWD. Gingivitis was noted as having 
bleeding in about 30% of the mouth. Out of the 4,169 women surveyed with the 
NHANES, 47.9% of them were considered to have gingivitis. Since 12 sites were 
measured in this study, those women who had 3 or more sites of bleeding were placed 
into the gingivitis category. For this study, gingivitis only presented in 44.6% of the 
women with VWD. When using a chi-square test to examine the difference in 
percentages, the Pearson’s correlation (0.169) showed that there was not a statistically 
significant difference between the control group and experimental group. This data is 
presented in Table 11. 
5.5.2 Limitations in Questionnaire Component 
The patient questionnaire also had limitations, specifically in measuring the 
severity of VWD. Not all patients had labs within their chart suggesting a recent VWF 
level. Also, research has shown a relationship between blood type and VWF level. Data 
on the patient’s blood type would have been helpful to be able to adequately control for 
severity of VWD.  
5.5.3 Limitations in the Clinical Examination 
Limitations also existed within the clinical component of this study. The indices 
used to measure plaque and gingival bleeding allowed for more consistency with 
measurements as well as more inter- and intra-examiner reliability since the possible 
outcomes for these variables were 0 or 1. Information on the amount of plaque and 
amount of gingival bleeding would have been helpful to accurately evaluate the 
relationship between the amount of gingival bleeding in this population. Also, tissue 
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integrity should have been taken into consideration. The gingival index would have 
allowed for a better description of the gingiva while the plaque index would have 
allowed for a more detailed description of the consistency of the dental plaque. 
5.5.4 Future Study Recommendations 
Due to the limitations of this study as well as the results, there are many 
recommendations for a future longitudinal study with a larger sample size and a true 
control group. Sharing the results of this current study could be used in grant writing to 
allow for more sponsorship for a larger, longitudinal study.  
A future study may choose to collect blood samples to analyze the VWF levels 
and other factors that could contribute to VWD such as Factor VIII. Blood type could 
also be analyzed to control for its effect on VWF levels, as proposed in current 
research. Labs could also be taken on the control group as well since VWF levels could 
fluctuate depending on menstrual cycle, pregnancy, oral contraceptive use, and age. A 
longitudinal study would allow data to be taken on patient’s VWF variability over time 
and how gingival bleeding is affected throughout the course of time and different life 
events. 
When collecting data on presence of plaque and gingival bleeding, presence of 
plaque could be measured by the SOHI index or the plaque index, and gingival bleeding 
could be measured by bleeding on probing, perhaps, or with the gingival index. Also, if 
pocket measurements were taken on all participants, the measurements between those 
with and without VWD could be compared as well. 
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Chapter 6 
 
Conclusions 
 
 This research study was conducted to examine the relationship between von 
Willebrand Disease (VWD) and gingival bleeding. Anecdotally, many people with 
bleeding disorders are afraid to perform adequate plaque removal along the gum line 
due to possibly causing bleeding of the gums. All studies that have been conducted 
previously have shown that plaque levels and gingival bleeding levels are not 
significantly different from the control group of people without VWD. Due to the high 
number of people with bleeding disorders that experience gingival bleeding, this study 
sought to assess if the gingival bleeding was related to presence of plaque even while 
controlling for possible confounding variables such as severity of VWD, oral hygiene 
habits, dental care utilization, and previous oral hygiene education delivery. 
 This study found that in women with VWD, when gingival bleeding is noted, it is 
more related to the presence of plaque than the level of VWF in the body. Also, having 
a dental hygienist present at bleeding disorder clinics leads to a decrease in the amount 
of plaque and gingival bleeding. This study also showed that women with VWD reported 
that they have been refused dental treatment and have felt bias from oral health care 
providers. Because of this access to dental care issue, it is important to have dental 
hygienists present at bleeding disorder treatment centers in order to educate patients 
with bleeding disorders and to increase awareness in other oral health care providers 
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about treating patients with bleeding disorders. Finally, having a dental hygienist 
present at bleeding disorder treatment centers can essentially help to bridge the gap 
between oral health and overall health. 
Though this study has provided much information about gingival bleeding and 
oral hygiene in women with VWD, future studies should be conducted using a larger 
sample size, a control group, and longitudinal design. Specifically, future studies should 
analyze the difference between those with and without VWD and assess the 
relationship between gingival bleeding and VWF levels over time in order to provide 
more evidence-based information to those with VWD about the relationship between 
their bleeding disorder and gingival bleeding. 
The results of this study can help oral health care providers to provide their 
patients with VWD evidence-based knowledge about plaque removal methods in order 
to prevent against gingival bleeding as well as the need for more extensive dental work 
which could indeed lead to treatment complications. Due to the evidence that women 
with VWD have been refused treatment and felt bias from an oral health care provider 
just shows how important it is to have a dental hygienist present at these bleeding 
disorder treatment centers in order to educate patients with bleeding disorders as well 
as other oral health care providers about treating patients with bleeding disorders. 
Having a dental hygienist present at bleeding disorder treatment centers can essentially 
help to bridge the gap between oral health and overall health. 
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Table 1 Abbreviations 
  
VWD von Willebrand Disease 
VWF von Willebrand Factor 
GBI Gingival bleeding index 
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Table 2 Possible outcomes for gingival bleeding index 
Code Description 
0 No gingival bleeding 
1 Gingival bleeding 
 
 
 
 
 
Table 3 Possible outcomes for plaque presence 
Code Description 
0 No plaque present 
1 Plaque present 
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Table 4 Descriptive statistics of sample 
 Percent 
Age 
   18-30 
   31-50 
   51-70 
 
40.9 
31.8 
27.3 
Race 
   Caucasian 
   African American 
   Asian 
   Hispanic 
   Other 
   Refused 
 
77.3 
9.1 
- 
4.5 
4.5 
4.5 
Education 
   Less than high school 
   HS and/or some college 
   College Degree 
   Refused 
 
- 
50.0 
47.7 
2.3 
Employment 
   None 
   Part Time 
   Full Time 
   Refused 
 
50.0 
9.1 
38.6 
2.3 
Dental Insurance 
   Yes 
   No 
   Refused 
 
72.7 
25.0 
2.3 
Alcohol Use 
   Yes 
   No 
   Refused 
 
61.9 
36.4 
4.5 
Tobacco Use 
   Yes 
   No 
   Refused 
 
4.5 
90.9 
4.5 
BLEEDING DISORDER TREATMENT CENTER 
   University of Michigan 
   Michigan State University 
 
45.5 
54.5 
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Table 5 Possible complications interfering with access to care for women with von 
Willebrand disease (VWD) 
 
Question Percentages Responses 
Have you ever 
avoided seeing a 
dentist? 
Yes – 38.6 
  Financial – 55.6 
  Anxiety – 44.4 
No – 59.1 
Refused – 2.3 
No insurance 
Anxiety, fear, afraid, pain 
I was told I bleed a lot 
Dislike the dentist 
“It’s not fun finding someone you trust” 
“Not feeling comfortable with their 
knowledge of my bleeding disorder” 
Has an oral health 
care provider ever 
refused you of 
treatment because 
of the possibility of 
bleeding disorder 
complications? 
Yes – 13.6 
No – 84.1 
Refused – 2.3 
“because of high danger of bleeding” 
“I have been sent away many times just 
for a basic cleaning” 
“It was tough at first to find a dentist who 
wasn’t nervous about liability of a BD 
when I was a kid” 
“Refuse to see because I had a blood 
disorder” 
“My bleeding time was 15 min” 
Have you ever felt 
any bias from any 
oral health care 
provider that you 
thought was due to 
your bleeding 
disorder? 
Yes – 9.1 
No – 79.5 
Refused – 11.4 
 
“High bleeding risk” 
“not willing to treat me” 
It was tough at first to find a dentist who 
wasn’t nervous about the liability of a BD 
when I was a kid” 
“complains about all the blood” 
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Table 6 Frequency table with number of sites with plaque  
 
 
 
Number of sites 
with plaque 
Frequency Percent 
0 5 11.4 
1 1 2.3 
2 5 11.4 
3 1 2.3 
4 3 6.8 
5 1 2.3 
6 1 2.3 
7 2 4.5 
8 0 0 
9 4 9.1 
10 5 11.4 
11 6 13.6 
12 10 22.7 
 
 
Out of the 12 sites measured per person 
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Table 7 Frequency table with number of sites with bleeding 
 
Number of sites 
with bleeding 
Frequency Percent 
0 16 36.4 
1 5 11.4 
2 3 6.8 
3 6 13.6 
4 4 9.1 
5 6 13.6 
6 1 2.3 
7 1 2.3 
8 1 2.3 
9 0 0 
10 1 2.3 
11 0 0 
12 0 0 
 
 
Out of the 12 sites measured per person 
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Table 8 Average number of sites (out of 12 sites measured) and standard deviations for 
each possible clinical outcome (Y=Yes, N=No, P=Plaque, B=Bleeding) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Table 9 Difference in means between possible outcome pairs as well as significance for 
paired samples t-test and when using linear regression to control for VWF level 
 Mean SD 
YPYB 1.95 2.27 
YPNB 5.32 4.36 
NPYB 0.45 0.76 
NPNB 4.27 4.31 
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 Difference in 
means 
P-value when 
comparing 
means 
P-value when 
controlling for VWF 
level 
YPYB v YPNB 3.47 < 0.01 0.82 
YPYB v NPYB 1.56 < 0.01 0.45 
YPNB v NPYB 5.02 < 0.01 0.53 
NPNB v NPYB 3.74 < 0.01 0.23 
YPYB v NPNB 3.47 < 0.01 0.22 
YPNB v NPNB 1.28 0.41 0.33 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 10 Multiple Linear Regression Model for Bleeding in Women with VWD. Gingival 
bleeding was the dependent variable. 
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Mean Number of Sites with Bleeding* 
Independent Variables Coefficient Estimate 
Std. 
Error P-Value 
95% CI 
 
VWF level 
    Less than 30 
    30-60 
    Greater than 60 
 
Ref 
0.367 
0.349 
 
Ref 
1.145 
0.891 
 
Ref 
0.750 
0.698 
 
Ref 
(-1.953, 2.686) 
(-1.457, 2.155) 
Age 
 -0.285 0.256 0.273 (-0.804, 0.234) 
Last DDS visit 
    Less than 6 months 
ago 
    More than 6 months 
ago 
 
Ref 
1.707 
 
Ref 
0.817 
 
Ref 
0.044 
 
Ref 
(0.051, 3.363) 
Data are shown as mean ± SE (95% CI)  
*Out of the 12 sites measured 
 
 
 
 
 
 
 
 
 
 
 
 
Table 11 Chi-square test for gingivitis in women from NHANES and women with VWD 
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 Gingivitis 
Study Yes No 
NHANES 1996 (47.9%) 
2173 
(52.1%) 
VWD 20 (55.6%) 
16 
(44.6%) 
Cases weighted by N 
Pearson’s Correlation: 0.169 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 59 
 
 
 
 
 
Figures 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1 
 60 
 
Percentage of participants within each von Willebrand Factor (VWF) level range (n=44). 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2 
vWF Levels
vWF < 30
vWF 30-60
vWF > 60
Missing Data
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Percentage of participants who brush less than once a day, once a day, and more than 
once a day (n=44). 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3 
Frequency of tooth brushing
Less than once a day
Once a day
More than once a day
No Response
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Percentage of participants who floss less than once a week, 1-6 times a week, and 
once or more a day (n=44). 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4 
Frequency of flossing
Less than once a week
1-6 times a week
Once or more per day
No Response
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Percentage of women, stratified by VWF level, perceived gingival health (n=44). This 
relationship is not significant (p=0.331). 
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Figure 5 
Percentage of women, stratified by VWF level, and frequency of gingival bleeding with 
tooth brushing and flossing (n=44). Neither relationship was significant (p>0.05). 
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Figure 6 
Percentage of participants and date of last dental visit (n=44). 
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Figure 7 
Percentage of those who stated that they have avoided seeing the dentist and likely 
reasons for avoidance (n=44). 
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Figure 8 
Average number of sites (out of the 12 measured sites) with plaque, stratified by VWF 
level.  
 
Avoided seeing a dentist
No
Yes - anxiety
Yes - financial
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Figure 9 
Average number of sites (out of the 12 sites measured) with gingival bleeding, stratified 
by VWF level. 
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Figure 10 
 70 
 
Each site had four possible outcomes (YPYB, YPNB, NPYB, and NPNB). The average 
number of sites (out of the 12 sites measured) for each possible outcomes was paired 
with other possible outcomes to determine the difference in means. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 11 
0
1
2
3
4
5
6
YPYB v YPNB YPYB v NPYB YPNB v NPYB NPNB v NPYB
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Average number of sites (out of 12) for each possible outcome when considering VWF 
level. When using ANOVA to determine the correlation between VWF levels and 
outcomes, none of the relationships were significant (p>0.05) 
 
 
 
 
 
 
 
 
Figure 12 
Error bars represent 95% CI 
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Number of sites with plaque and bleeding depending on patient perception of bleeding 
upon flossing (p>0.05) 
 
 
 
 
 
 
 
 
 
 
Figure 13 
Error bars represent 95% CI 
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Percentage of sites with plaque present depending on how frequently oral health 
education is reviewed at the bleeding disorder treatment center (p=0.031) 
 
 
 
 
 
 
 
 
 
 
Figure 14 
Error bars represent 95% CI 
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Average number of sites (out of the 12 sites measured) with bleeding upon flossing 
when considering whether oral health education is delivered to patients with VWD 
(p=0.033) 
 
 
 
 
 
 
 
 
Figure 15 
Error bars represent 95% CI 
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There was not a statistically significant difference between gingivitis occurring in the 
women with VWD when compared to the women who participated in the NHANES study 
(Pearson correlation= 0.169). 
 
 
 
 
 
 
 
 
 
 
Error bars represent 95% CI 
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Appendix A 
Participant Questionnaire 
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Oral Hygiene Education and Oral Health of Women with von Willebrand Disease 
 
Date: _________ Initials: ________ Patient ID: _________ 
Thank you very much for filling out this questionnaire. All of your answers are strictly 
confidential. Your name will not appear on any of the materials containing data. Please 
be honest and try to answer all of the questions below. 
 
1. How old are you? 
a. I am ________years old. 
2. What is your ethnic/racial background? 
a. Caucasian 
b. African American 
c. Asian 
d. Hispanic 
e. Other ___________________ 
3. What is your highest level of education completed? 
a. Less than high school 
b. High school 
c. Some college 
d. Associates Degree 
e. Bachelor’s Degree 
f. Master’s Degree 
g. PhD 
4. What is your employment status? 
a. Full-Time 
b. Part-Time 
c. None 
5. Do you have dental coverage? 
a. Yes 
b. No 
6. Do you drink alcohol? 
a. Yes 
b. No 
7. If yes, how many drinks do you have per week? ______ 
8. Do you smoke cigarettes/cigars/pipe? 
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a. Yes 
b. No 
9. If yes, how much do you smoke per day? ______ 
 
10. Which bleeding disorder treatment center do you visit? 
a. University of Michigan Hemophilia and Coagulation Disorders in Ann Arbor, MI 
b. Michigan State University Center for Bleeding and Clotting Disorders in East 
Lansing, MI 
c. Henry Ford Hospital Hemophilia and Thrombosis Treatment Center in Detroit, MI 
11. How often do you visit your treatment center? 
a. Less than once a year 
b. Once a year 
c. More than once a year 
12. How often does someone at your treatment center discuss oral health with you? 
a. Never 
b. Rarely 
c. Occasionally 
d. Frequently 
e. At every visit 
13. Who usually discusses the importance of oral health with you? 
a. Hematologist 
b. Dental hygienist at your treatment center 
c. Dental hygienist or dentist outside your treatment center 
d. Other 
e. No one 
14. How would you describe the health of your gums? 
a. Poor 
b. Fair 
c. Good 
d. Very Good  
e. Excellent 
 
 
15. How would you describe the health of your teeth? 
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a. Poor 
b. Fair 
c. Good 
d. Very Good 
e. Excellent 
16. How important is your oral health to you? 
a. Not at all important 
b. Somewhat important 
c. Very important 
17. How often do you experience a gum bleed? 
a. Less than once a month 
b. 1-2 times a month 
c. 3-4 times a month 
d. More than 4 times a month 
18. How often do your gums bleed when brushing? 
a. Never 
b. Hardly ever 
c. On occasion 
d. Fairly often 
e. Very often 
19. How often do your gums bleed when flossing? 
a. Never 
b. Hardly ever 
c. On occasion 
d. Fairly often 
e. Very often 
20. How often do you experience pain in your mouth? 
a. Never 
b. Hardly ever 
c. On occasion 
d. Fairly often 
e. Very often 
 
21. How often do you brush your teeth? 
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a. Less than once a day 
b. Once a day 
c. Twice a day 
d. More than twice a day 
22. How often do you floss? 
a. Less than once a week 
b. 1-3 times a week 
c. 4-6 times a week 
d. Once a day 
e. More than once a day 
23. Which of the following products, if any, do you use to maintain oral health?  
(Select all that apply). 
a. Mouthwash 
b. WaterPik 
c. Interdental brush 
d. Toothpick 
e. Stimudent 
f. Other _____________ 
24. When was the last time you visited a dentist? 
a. 0-3 months ago 
b. 3-6 months ago 
c. 6-12 months ago 
d. Over 12 months ago 
25. Have you ever avoided seeing a dentist? 
a. Yes 
b. No 
26. If yes, what was the reason for not maintaining regular visits? 
 
27. Has an oral health care provider ever refused you of treatment because of the possibility 
of bleeding disorder complications? 
a. Yes 
b. No 
28. If yes, please explain. 
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29. Have you ever felt any bias from any oral health care provider that you thought was due 
to your bleeding disorder? 
a. Yes 
b. No 
30.  If yes, please explain. 
 
31. Are you pre-menopausal? 
a. Yes 
b. No 
32. If yes, when was your last menstrual period? ________________ 
 
33. Are you taking oral contraceptives (birth control pills) or another method such as an IUD 
to control menstrual bleeding? 
a. Yes 
b. No 
34. If yes, please explain. 
 
 
Thank you very much for answering all of the questions presented above. If you have any 
questions regarding this questionnaire, please contact  
Stefanie Marx by phone: (586) 804-2610 or by email: stefmarx@umich.edu 
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Appendix B 
Chart Data Sheet 
Patient ID: __________ Date of Data Extraction: __________ Patient DOB: 
__________ 
1. Diagnosis Information 
a. Type of Von Willebrand Disease: 
 
b. Last Von Willebrand factor levels/Date: 
 
c. Date of VWD Diagnosis: 
 
d. Treatment: 
 
 
 
2. Medical History 
a. Other medical conditions: 
 
 
 
b. Medications: 
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Appendix C 
Oral Examination Form 
Patient ID: __________ Date of Examination: __________ Patient DOB: 
__________ 
Plaque Accumulation (0=No Plaque, 1=Plaque Present) 
 Distobuccal Buccal Mesiobuccal Distolingual Lingual Mesiolingual 
3       
9       
12       
19       
25       
28       
 
Gingival Bleeding Index (0=No Bleeding, 1=Bleeding) 
 Distal Mesial 
3   
9   
12   
19   
25   
28   
 
Visible oral manifestations: 
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APPENDIX D 
 
 
 Medical School Institutional Review Board (IRBMED) • 2800 Plymouth Road, Building 520, Room 3214, Ann Arbor, MI 48109-2800 • phone (734) 763 4768 • fax (734) 763 
9603 • irbmed@umich.edu 
 
  
  
 
To: Stefanie Marx     
From:  
Michael Geisser 
Alan Sugar 
 
  
Cc:  
  
Stefanie Marx 
Karen Ridley 
Jill Bashutski 
Linda Taichman 
 
  
Subject:Initial Study Approval for [HUM00077611] 
  
SUBMISSION INFORMATION: 
Study Title: Gingival Bleeding and Oral Hygiene of Women with von Willebrand Disease 
Full Study Title (if applicable): 
Study eResearch ID: HUM00077611  
Date of this Notification from IRB:10/7/2013  
Review:Expedited  
Initial IRB Approval Date: 9/30/2013 
Current IRB Approval Period:9/30/2013 - 9/29/2014  
Expiration Date: Approval for this expires at 11:59 p.m. on 9/29/2014 
UM Federalwide Assurance (FWA): FWA00004969 (For the current FWA expiration date, please 
 85 
 
visit the UM HRPP Webpage)  
OHRP IRB Registration Number(s): IRB00001999 
  
Approved Risk Level(s):  
Name Risk Level 
HUM00077611 No more than minimal risk 
 
NOTICE OF IRB APPROVAL AND CONDITIONS: 
The IRBMED has reviewed and approved the study referenced above. The IRB determined that the 
proposed research conforms with applicable guidelines, State and federal regulations, and the 
University of Michigan's Federalwide Assurance (FWA) with the Department of Health and Human 
Services (HHS). You must conduct this study in accordance with the description and information 
provided in the approved application and associated documents.  
APPROVAL PERIOD AND EXPIRATION: 
The approval period for this study is listed above. Please note the expiration date. If the approval 
lapses, you may not conduct work on this study until appropriate approval has been re-
established, except as necessary to eliminate apparent immediate hazards to research subjects. 
Should the latter occur, you must notify the IRB Office as soon as possible. 
IMPORTANT REMINDERS AND ADDITIONAL INFORMATION FOR INVESTIGATORS 
APPROVED STUDY DOCUMENTS: 
You must use any date-stamped versions of recruitment materials and informed consent 
documents available in the eResearch workspace (referenced above). Date-stamped materials are 
available in the “Currently Approved Documents” section on the “Documents” tab. 
RENEWAL/TERMINATION: 
At least two months prior to the expiration date, you should submit a continuing review 
application either to renew or terminate the study. Failure to allow sufficient time for IRB review 
may result in a lapse of approval that may also affect any funding associated with the study. 
AMENDMENTS: 
All proposed changes to the study (e.g., personnel, procedures, or documents), must be approved 
in advance by the IRB through the amendment process, except as necessary to eliminate 
apparent immediate hazards to research subjects. Should the latter occur, you must notify the IRB 
Office as soon as possible. 
AEs/ORIOs: 
You must inform the IRB of all unanticipated events, adverse events (AEs), and other reportable 
information and occurrences (ORIOs). These include but are not limited to events and/or 
information that may have physical, psychological, social, legal, or economic impact on the 
research subjects or other. 
Investigators and research staff are responsible for reporting information concerning the 
approved research to the IRB in a timely fashion, understanding and adhering to the reporting 
guidance (http://www.med.umich.edu/irbmed/ae_orio/index.htm), and not implementing any 
changes to the research without IRB approval of the change via an amendment submission. When 
changes are necessary to eliminate apparent immediate hazards to the subject, implement the 
change and report via an ORIO and/or amendment submission within 7 days after the action is 
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taken. This includes all information with the potential to impact the risk or benefit assessments of 
the research. 
SUBMITTING VIA eRESEARCH: 
You can access the online forms for continuing review, amendments, and AEs/ORIOs in the 
eResearch workspace for this approved study (referenced above). 
MORE INFORMATION: 
You can find additional information about UM’s Human Research Protection Program (HRPP) in 
the Operations Manual and other documents available at: www.research.umich.edu/hrpp. 
  
Michael Geisser  
Co-chair, IRBMED 
Alan Sugar 
Co-chair, IRBMED 
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Appendix E 
Informed Consent Document 1 
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Appendix F 
Informed Consent Document 2 
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